Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study

NAActive, not recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2026

Conditions

Glioblastoma

Interventions

DIAGNOSTIC_TEST

PET imaging

The evaluation of PET imaging using PET ligand \[18F\]JNJ-64413739 or a \[18F\] labeled equivalent in vivo in patients.

Trial Locations (1)

Kepler University Hospital, Linz

All Listed Sponsors

lead

Kepler University Hospital

OTHER

NCT05753995 - Immuno-Positron Emission Tomography (PET)-Glioma Study, a Proof-of-principle Imaging Study | Biotech Hunter | Biotech Hunter